JUNS — Jupiter Neurosciences Balance Sheet
0.000.00%
- $20.53m
- $16.91m
Annual balance sheet for Jupiter Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.208 | 0.331 | 0.064 | 0.028 | 3.77 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.126 | 0 | — | — | 0.767 |
Total Other Current Assets | |||||
Total Current Assets | 0.55 | 0.455 | 0.07 | 0.029 | 4.65 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 0.209 | 0.163 | 0.116 | 0.07 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.55 | 0.667 | 0.236 | 0.149 | 6.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.26 | 5.68 | 7.26 | 5.77 | 2.01 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.26 | 5.85 | 7.38 | 5.95 | 2.03 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -3.71 | -5.18 | -7.14 | -5.8 | 4.17 |
Total Liabilities & Shareholders' Equity | 0.55 | 0.667 | 0.236 | 0.149 | 6.2 |
Total Common Shares Outstanding |